EG12290A - Process for preparing of mixed of polyols - Google Patents

Process for preparing of mixed of polyols

Info

Publication number
EG12290A
EG12290A EG784/76A EG78476A EG12290A EG 12290 A EG12290 A EG 12290A EG 784/76 A EG784/76 A EG 784/76A EG 78476 A EG78476 A EG 78476A EG 12290 A EG12290 A EG 12290A
Authority
EG
Egypt
Prior art keywords
polyols
preparing
mixed
Prior art date
Application number
EG784/76A
Inventor
J Ricard
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH17376A external-priority patent/CH616911A5/fr
Priority claimed from CH979076A external-priority patent/CH617175A5/en
Application filed by Om Lab Sa filed Critical Om Lab Sa
Application granted granted Critical
Publication of EG12290A publication Critical patent/EG12290A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
EG784/76A 1976-01-08 1976-12-21 Process for preparing of mixed of polyols EG12290A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH17376A CH616911A5 (en) 1976-01-08 1976-01-08
CH979076A CH617175A5 (en) 1976-07-30 1976-07-30 Processes for the preparation of mixed polyol esters

Publications (1)

Publication Number Publication Date
EG12290A true EG12290A (en) 1979-06-30

Family

ID=25683750

Family Applications (1)

Application Number Title Priority Date Filing Date
EG784/76A EG12290A (en) 1976-01-08 1976-12-21 Process for preparing of mixed of polyols

Country Status (18)

Country Link
JP (1) JPS5285139A (en)
BG (1) BG27537A3 (en)
CA (1) CA1075708A (en)
DD (1) DD128400A5 (en)
DE (1) DE2654951A1 (en)
EG (1) EG12290A (en)
ES (1) ES453795A1 (en)
FI (1) FI763529A (en)
FR (1) FR2337552A1 (en)
GB (1) GB1572035A (en)
GR (1) GR61818B (en)
IL (1) IL51039A0 (en)
NL (1) NL7613457A (en)
PL (1) PL117246B1 (en)
PT (1) PT65894B (en)
RO (1) RO70355A (en)
SE (1) SE7613426L (en)
YU (1) YU286476A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL176551C (en) * 1979-04-25 1985-05-01 Shell Int Research PROCESS FOR PREPARING AN AROMATIC HYDROCARBON MIXTURE BY CATALYTIC CONVERSION OF A MIXTURE OF CARBON MONOXIDE AND HYDROGEN.

Also Published As

Publication number Publication date
RO70355A (en) 1981-08-17
SE7613426L (en) 1977-07-09
DD128400A5 (en) 1977-11-16
GR61818B (en) 1979-01-22
DE2654951A1 (en) 1977-07-21
CA1075708A (en) 1980-04-15
PT65894B (en) 1978-05-18
PL194851A1 (en) 1979-05-07
PT65894A (en) 1976-12-01
YU286476A (en) 1982-08-31
GB1572035A (en) 1980-07-23
ES453795A1 (en) 1978-01-16
FI763529A (en) 1977-07-09
NL7613457A (en) 1977-07-12
IL51039A0 (en) 1977-02-28
PL117246B1 (en) 1981-07-31
BG27537A3 (en) 1979-11-12
JPS5285139A (en) 1977-07-15
FR2337552A1 (en) 1977-08-05

Similar Documents

Publication Publication Date Title
JPS5331604A (en) Process for preparing metalacids of organicacid
EG12406A (en) Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS52110775A (en) Process for manufacture of fiberrretnforced foam
EG14072A (en) Process for preparing of meta-aryloxy-benzaldehydes
EG13080A (en) Process for preparing of gamma-pyrones
PT66317A (en) Process for preparation of 3-halomethylcephens
GR61990B (en) Preparation process of ((quinolyl-4)-3propyl-1)-4piperidines
EG13191A (en) Process for preparing of quinoxaline-di-n-oxide derivatives
JPS5368797A (en) Novel compounds and process for preparing same
JPS5285145A (en) Process for manufacture of 22halocyclobutanone
JPS5285218A (en) Process for manufacture of perinone series dyestuffs
CS190339B2 (en) Process for preparing derivatives of sulphonyl-benzimidazole
EG12290A (en) Process for preparing of mixed of polyols
IL51433A (en) Process for preparation of 7-alkoxy-3-chloromethylcephems
GR63624B (en) Process for preparation of new aryl-alkylamine
PT67465A (en) Process for preparing of haloacylamides
CS192475B2 (en) Process for preparing derivatives of triphenylalkene
EG12776A (en) Process for preparing of zearalin ethers
IL51653A (en) Process for preparation of 3-hydroxymethylcephems
EG12217A (en) Process for preparing of 6-deoxytetracyclines
EG12921A (en) Process for preparing of m-phenoxybenzamide derivatives
JPS5384916A (en) Process for preparing mixture of 22ketoglonate and ketogluconate
KR780000711B1 (en) Process for preparation of l-4-hydroxyphenylclycine
JPS5387391A (en) Cephalospoline systmem compounds and process for preparing same
JPS5377100A (en) Novel process for preparing rutecarpine